MICRODOSING

Abstract

A dosing system for transferring an aseptic fluid in dosages into a container, comprising a peristaltic pump configured such that the filling accuracy for fill volumes of the aseptic fluid <100 μL is ±3 μL.

Claims

1-25. (canceled)

26. A dosing system for transferring an aseptic fluid in dosages into a container, comprising: a peristaltic pump configured to provide a filling accuracy of ±3 μL for fill volumes of the aseptic fluid of less than 100 μL.

27. The dosing system according to claim 26, wherein the aseptic fluid is a liquid mAbs solution.

28. The dosing system according to claim 26, wherein the filling accuracy is ±1.54, for the fill volumes of the aseptic fluid of less than 50 μL.

29. The dosing system according to claim 26, wherein the filling accuracy is ±1.04, for the fill volumes of the aseptic fluid of less than 30 μL.

30. The dosing system according to claim 26, wherein the filling accuracy is ±0.50_, for the fill volumes of the aseptic fluid of less than 20 μL.

31. The dosing system according to claim 26, wherein the filling accuracy is ±0.050_, for the fill volumes of the aseptic fluid of less than 12 μL.

32. The dosing system according to claim 26, wherein the dosing system comprise surfaces manufactured from a sterilizable material.

33. The dosing system according to claim 26, wherein the aseptic fluid has a viscosity of less than 15 cP±2 cP.

34. The dosing system according to claim 26, wherein the aseptic fluid has a viscosity of 16 cP±1 cP.

35. The dosing system according to claim 26, wherein the aseptic fluid has a viscosity of less than 1500 cP±20 cP.

36. The dosing system according to claim 26, wherein the aseptic fluid has a viscosity of 1480 cP±1 cP.

37. The dosing system according to claim 26, wherein the peristaltic pump comprises a flexible tube, a counter pressure element, a plurality of actors and a drive, wherein the flexible tube is arranged along the counter pressure element, the actors are moveable by the drive in relation to the flexible tube, the flexible tube is compressible between the actors and the counter pressure element by moving the actors, the flexible tube is essentially straightly arranged along the counter pressure element thereby forming a longitudinal axis, the actors are arranged parallel to each other along the longitudinal axis of the flexible tube, and each of the actors is independently and linearly moveable by the drive along an actuation axis essentially perpendicular to the longitudinal axis of the flexible tube from a home position, in which the flexible tube is open for a fluid to pass, to an end position, in which the flexible tube is compressed and sealed.

38. The dosing system of claim 37, wherein the flexible tube of the peristaltic pump is partially pre-compressed between the plurality of actors and the counter pressure element when all actors of the plurality of actors are in their home positions.

39. The dosing system according to claim 26, further comprising a liquid flow measurement sensor connected to the peristaltic pump that is configured to report a volume of fluid passed through the peristaltic pump.

40. The dosing system according to claim 39, further comprising a control unit coupled to the peristaltic pump and coupled to the liquid flow measurement sensor, wherein the control unit is configured to receive a data signal from the liquid flow measurement sensor, to evaluate the received data signal, and to adapt the peristaltic pump in accordance with the evaluated data signal, wherein adapting the peristaltic pump comprises adjusting a volume dispensed by the peristaltic pump.

41. A process for controlling the accuracy of the dosing system according to claim 26, wherein a dispensed volume of the aseptic fluid by the peristaltic pump is measured by a capacitive pressure sensor connected to the peristaltic pump for reporting a volume of a fluid passed through the peristaltic pump.

42. The process according to claim 41, wherein the capacitive pressure sensor measures a change of capacitance in an orifice of the capacitor, when a fluid is between electrodes of the capacitive pressure sensor compared to a capacitance of air.

43. The process according to claim 41, wherein the dispensed volume is 50 μL±3 μL and is dispensed according to the following settings: 6±1 cycles, in particular 2±1 cycles, 30 Hz±10 piezo frequency, in particular 30 Hz±1 piezo frequency.

44. The process according to claim 41, wherein the dosing system includes a tubing having an internal diameter of between 1.6 mm and 0.8 mm.

45. The process according to claim 41, wherein the dosing system includes a tubing with a wall thickness of 1.6 mm.

46. The process according to claim 41, wherein the peristaltic pump is controlled in accordance with the dispense volume of the fluid reported by the capacitive pressure sensor, wherein controlling the peristaltic pump comprises adjusting a volume dispensed by the peristaltic pump.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

[0119] FIG. 1 A schematic view of a first embodiment of a peristaltic pump;

[0120] FIG. 2 A schematic view of a dosing system comprising a peristaltic pump;

[0121] FIG. 3 A schematic view of a peristaltic pump in a first state within a process;

[0122] FIG. 4 A schematic view of the peristaltic pump of FIG. 3 in a second state within the process of FIG. 3;

[0123] FIG. 5 A schematic view of the peristaltic pump of FIG. 3 in a third state within the process of FIG. 3;

[0124] FIG. 6 A schematic view of the peristaltic pump of FIG. 3 in a fourth state within the process of FIG. 3.

[0125] FIG. 7 A sensor concept of a reliable in-process control method for low fill volumes,

[0126] FIG. 8 Dosing accuracy of 3×50 single doses, the upper line of measuring points shows the accuracy of degassed water, the lower line of measuring points the accuracy for a high-viscous model glycerol-water solution (16.49 cP),

[0127] FIG. 9 Linearity of the fill volume range for two different tubings. Triangles show the volume range for a Tubing with ID=1.6 mm and a wall thickness of 1.6 mm. Squares show the volume range for a Tubing with ID=0.8 mm and a wall thickness of 1.6 mm,

[0128] FIG. 10 Comparison of different pumps. Two different liquid fluids were recirculated up to 15 times in three different pumps. Dark grey columns represent a liquid fluid without surfactant while the light-grey columns represent a liquid fluid with surfactant. Highest particle counts were found after piston pump recirculation. Radial peristaltic pump filling resulted in higher subvisible particle counts than linear peristaltic pump filling.

DESCRIPTION OF EMBODIMENTS

[0129] In the following description certain terms are used for reasons of convenience and are not to be interpreted as limiting. The terms “right”, “left”, “up”, “down”, “top” and “bottom” refer to directions in the figures. The terminology comprises the explicitly mentioned terms as well as their derivations and terms with a similar meaning.

[0130] FIG. 1 shows a first embodiment of a linear peristaltic pump 1 of a dosing system according to the invention. In addition to the peristaltic pump 1, the dosing system comprises a control unit 26 and a capacitive pressure sensor 27 as described below in connection with FIG. 7. The peristaltic pump 1 comprises a flexible tube 13, a tube extension jacket 14 as tube fixation structure, a counter pressure plate 12 as counter pressure element, a set of ten parallel piezoelectric actors 11, a dispensing needle 15 as filling needle and a piezoelectric drive unit 17 housing the actors 11 as drive. The tube extension jacket 14 has two straps 141 and a tubular net portion 142. A fixation section 131 of the flexible tube 13 projects through the net portion 142 of the tube extension jacket 14. On expanding the net portion 142, e.g. by pulling the straps 141, it narrows its interior and fixes the flexible tube 13.

[0131] Following the tube extension jacket 14 to the right the flexible tube 13 passes on in between a flat surface of the counter pressure plate 12 and actuation faces of the actors 11. The flat surface of the counter pressure plate 12 forms a guidance along which the flexible tube 13 is straightly arranged. Thus, the flexible tube 13 has a longitudinal axis extending in a longitudinal direction 135 which is identical to the direction of advancing the fluid. The counter pressure plate 12 is fixedly or immovably arranged relative to the flexible tube 13, the dispensing needle 15 and the drive unit 17.

[0132] The actors 11 are adjacently arranged in parallel such that their actuation faces constitute an essentially continuous front face directed to the flexible tube 13. The piezoelectric drive unit 17 can linearly move each of the actors 11 independently from each other in a stroke direction which is perpendicular to the longitudinal direction 135. The flexible tube 13 is pre-compressed in between the counter pressure plate 12 and the actors 11. For that reason, it has a narrowing section 132 between the tube extension jacket 14 and the counter pressure plate 12 and a widening section 134 between the counter pressure plate 12 and a cap nut 16 following the counter pressure plate 12 to the right. Like this, the flexible tube 13 is clamped and fixedly aligned with regard to the counter pressure plate 12 and the actors 11.

[0133] In FIG. 1 the four leftmost actors 11 and the three rightmost actors 11 are in a home position in which they are at a maximum distance to the counter pressure plate 12. The sixth actor 11 counted from the left which is the fifth actor 11 counted from the right is moved by the drive unit 17 into its end position in which a side of the wall of the flexible tube 13 contacting the actors 11 is transversally or radially pressed onto a side of the wall of the flexible tube 13 contacting the counter pressure plate 12. Thereby, the flexible tube 13 is elastically compressed and its inner duct is sealed such that so fluid can pass the actors 11. The two actors 11 neighboring the actor 11 which is in its end position are moved by the drive unit 17 in a position between their home positions and their end positions. Thereby, the moved actors induce a wave portion 133 on the flexible tube 13.

[0134] The widening section 134 of the flexible tube 13 passes over into the dispensing needle 15 which is fixed to the piezoelectric drive unit 17 and the counter pressure plate 12 via the cap nut 16. The dispensing needle 15 has a proximal or left-hand body portion 151 and a distal or right-hand pipe portion 152.

[0135] In use, the peristaltic pump 1 of the dosing system can be operated in two modes or schemes for providing dosages of the fluid out of the open end of the pipe portion 152 of the dispensing needle 15. In a first path control mode, the actors 11 are identically moved one after the other. In a first step the leftmost actor 11 is moved to its end position and the right side neighboring actor 11 is partially moved into the direction of its end position. All the other actors 11 are in their home positions. In a second step the second leftmost actor 11 is moved to its end position and the two neighboring actors 11 are partially moved into the direction of their end position. All the other actors 11 are in their home positions. In a third step the third leftmost actor 11 is moved to its end position and the two neighboring actors 11 are partially moved into the direction of their end position. All the other actors 11 are in their home positions. This stepwise moving of the actors 11 is continued until in a tenth step the rightmost actor 11 is moved to its end position and the left side neighboring actor 11 is partially moved into the direction of its end position. All the other actors 11 are in their home positions. After the tenth step the process is restarted with the first step.

[0136] By moving the actors as described hereinbefore, a wave is generated in the side wall of the flexible tube 13. This wave pushes an exactly predefined volume of the fluid forward into the longitudinal direction 135 to the right. Thereby, the predefined volume of the fluid passes the dispensing needle 15 and exits the open end of the pipe portion 152. The overall volume of one single dosage can be defined by the number of cycles of generating the wave with the actors 11. It can also be less than one full cycle by running plural offset cycles at the same time.

[0137] In a second time-pressure control mode of operating the peristaltic pump 1, one or plural actors 11 are moved into the end position thereby sealing the flexible tube 13. Upstream the actors 11, the fluid is set under pressure. By moving the one or plural actors 11 back into the home position, the fluid is advanced by the overpressure into the longitudinal direction 135 to the right and out of the open end of the pipe portion 152 of the dispensing needle 15. After a specific time the one or plural actors 11 are moved again in the end position and the flexible tube 13 is sealed again.

[0138] In the time-pressure mode, the dispensed volume is predefined by the time the flexible tube 13 is open and by the pressure in the fluid upstream the actors 11. In a given diameter of the flexible tube 13, the higher the pressure and/or the longer the time are the larger the dispensed volume of fluid is.

[0139] In the control unit 26 various parameters of operation of the dosing system and, in particular of its peristaltic pump 1 can be set. General parameters of operation can comprise: number of actors 11, wave speed corresponding to the speed the steps of the actors 11 are advanced and dimension of the wave depending on the number and stroke of simultaneously moved actors 11, e.g. in percent of the path between home position and end position. Parameters specific for the path control mode can comprise: the path length the wave has to travel which, e.g., can be between 0.1 millimeter (mm) and 1,000 mm, the time in which the wave travels the path lengths which, e.g., can be between 1 millisecond (ms) and 10,000 ms. Parameter specific for the time-pressure mode can comprise: identification of the actor(s) 11 sealing the flexible tube, time the flexible tube 13 is opened for one single dosage and pressure of the fluid upstream the actors 11. The control unit 26 monitors the parameters and controls the pressure and the actors 11 via the drive unit accordingly.

[0140] In FIG. 2 an embodiment of a dosing system 2 according to the invention having a second embodiment of a peristaltic pump 18 is shown. In addition to the peristaltic pump 18, the dosing system 2 comprises a control unit 26 and a capacitive pressure sensor 27 as described below in connection with FIG. 7. The peristaltic pump 18 is similarly embodied as the peristaltic pump 1 shown in FIG. 1. It has a dispensing needle 158, a flexible tube 138, a counter pressure plate 128 as counter pressure element and a piezoelectric drive unit 178 housing six parallel piezoelectric actors 118 as drive. The peristaltic pump 18 further comprises a tank 188 as fluid reservoir being connected to a right hand or upstream end of the flexible tube 138.

[0141] The dosing system 2 further comprises a pressure regulator 21 being connected to the tank 188. By means of the pressure regulator 21 a pressure of the fluid inside the tank 188 can be adjusted. The tank 188 is connected to a level sensor 22 sensing a filling level of the tank 188. By means of the level sensor 22 a fluid level of the tank 188 can be monitored and controlled by the control unit 26.

[0142] The dispensing needle 158 is positioned inside a needle container 23 to which a temperature gauge 24 and a condensation trap 25 are connected. By means of the needle container 23 a pressurizeable unit is built for steam sterilization. Thereby, clean steam, e.g. of a temperature above 121° C., can pass through the complete fluid path of the filling apparatus 2 for killing life microorganisms from the tank 188 to a open end of the dispensing needle 158. After leaving the dispensing needle 158, the stem fills the needle container 158 and also sterilizes the outer surface of the dispensing needle 158. Condensate that is developing from the steam is drained away from the needle container 23 towards the condensate trap 25 and discarded there. Like this, it can be made sure by applying the steam that a pressure of two bar is built up such that satisfactory sterilization conditions can be provided, e.g. over a time of fifteen minutes.

[0143] The dosing system 2 also comprises a vial holder as container holder and a linear robot as dosing system positioner. The linear robot is arranged to position the needle container 23 together with the peristaltic pump 18 adjacent to a vial held by the vial holder. Like this, the linear robot allows to bring a point of dose close to a point of fill which makes a very precise filling or dosing possible.

[0144] FIG. 3 shows a third embodiment of a peristaltic pump 19 of a dosing system according to the invention being operated in an embodiment of a process according to the invention. The peristaltic pump 19 is similarly embodied as the peristaltic pump 1 shown in FIG. 1 and the peristaltic pump 18 shown in FIG. 2. In a downstream or top-down direction the peristaltic pump 19 comprises a fluid reservoir 189 being connected to a top longitudinal end of a flexible tube 139. The reservoir 189 holds a fluid to dose at an elevated pressure. The flexible tube 139 extends between a counter pressure plate 129 and a ten parallel actors 119, wherein the flexible tube 139 is pre-compressed between the counter pressure plate 129 and the actors 119. The ten actors are housed in a piezoelectric drive unit 179. At its bottom or downstream longitudinal end the flexible tube 139 is connected to a dispensing needle 159. The ten actors 119 are numbered in FIG. 1 from top or upstream first actor 119 to bottom or downstream tenth actor 119.

[0145] In FIG. 3 the peristaltic pump 19 is shown in an early stage of the process in which the fifth and the sixth actors 119 are moved by the piezoelectric drive unit 179 into their end positions. Thereby, these two actors 119 seal the flexible tube 139 such that, as indicated by the top arrow, the fluid can only advance up to the fifth actor 11. Additionally, the ninth actor 119 is moved by the drive unit 179 into an intermediate position which lies in between the home and end positions.

[0146] In the intermediate position the ninth actor 119 slightly compresses the flexible tube 139 without preventing that fluid can pass.

[0147] The following applies to the rest of this description. If, in order to clarify the drawings, a figure contains reference signs which are not explained in the directly associated part of the description, then it is referred to previous description sections.

[0148] FIG. 4 shows the peristaltic pump 19 in a following stage of the process. Compared to the early stage shown in FIG. 3 the fifth and sixth actors 119 are moved into their home positions by the drive unit 179. The ninth actor 11 still is in its intermediate position. This allows the pressurized fluid to pass through the flexible tube 139 and the dispensing needle 159 into a container to be filled as indicated by the right hand arrow. The peristaltic pump 19 is operated in a time-pressure mode as explained hereinbefore.

[0149] As shown in FIG. 5, after a predefined time allowing a predefined amount of the fluid to be dispensed out of the dispensing needle 159, the fifth and the sixth actors 119 are moved into their end positions again. The ninth actor 11 still is in its intermediate position. Thereby, the flexible tube 139 is sealed again and the fluid may only advance up to the fifth actor 119.

[0150] In FIG. 6 the peristaltic pump 19 is shown in a further stage of the process. In this stage the ninth actor 119 is moved back into its home position by the drive unit 117. The fifth and sixth actors 119 still are in their end positions sealing the flexible tube 139. By moving the ninth actor back a negative pressure is induced in the lower part of the flexible tube 139. This results in a back sucking effect in the lower part of the flexible tube 139 which allows for preventing leakage and loss of fluid. For providing a next dosage of the fluid the process is repeated.

[0151] FIG. 7 shows the control unit 26 and the capacitive pressure sensor 27 of the dosing systems described in FIGS. 1 to 6. More specifically, FIG. 7A shows the control unit 26 and the capacitive pressure sensor 27 prior being operated and FIG. 7B shows the control unit 26 and the capacitive pressure sensor 27 while being operated.

[0152] The capacitive pressure sensor 27 is directed towards a vial 3 as container which is filled with a mAb solution 4 as aseptic fluid. Further, the capacitive sensor 27 is connected to the control unit 26 by a data communication cable. The capacitive sensor 27 provides a data signal to the control unit 26 as feedback with regard to the volume of the mAb solution 4 filled into the vial 3. The control unit 26 uses the feedback to control the peristaltic pump 1, 18, 19 as to its filling volumes.

[0153] For controlling the peristaltic pump 1, 18, 19, the control unit 26 controls the compression force acting on the flexible tube 13, 138, 139. Thereby, the control unit 26 adjusts the length of the path of the actuators 11, 118, 119 by adjusting the pre-compression of the flexible tube 13, 138, 139. With such a force control the dosage amount of fluid is precisely kept on a constant level over the time.

[0154] While the invention has been illustrated and described in detail in the drawings and foregoing description, such illustration and description are to be considered illustrative or exemplary and not restrictive. It will be understood that changes and modifications may be made by those of ordinary skill within the scope and spirit of the following claims. In particular, the present invention covers further embodiments with any combination of features from different embodiments described above and below.

[0155] The invention also covers all further features shown in the Figs. individually although they may not have been described in the afore or following description. Also, single alternatives of the embodiments described in the figures and the description and single alternatives of features thereof can be disclaimed from the subject matter of the invention or from disclosed subject matter. The disclosure comprises subject matter consisting of the features defined in the claims ort the exemplary embodiments as well as subject matter comprising said features.

[0156] Furthermore, in the claims the word “comprising” does not exclude other elements or steps, and the indefinite article “a” or “an” does not exclude a plurality. A single unit or step may fulfill the functions of several features recited in the claims. The mere fact that certain measures are recited in mutually different dependent claims does not indicate that a combination of these measures cannot be used to advantage. The terms “essentially”, “about”, “approximately” and the like in connection with an attribute or a value particularly also define exactly the attribute or exactly the value, respectively. The term “about” in the context of a given numerate value or range refers to a value or range that is, e.g., within 20%, within 10%, within 5%, or within 2% of the given value or range. Any reference signs in the claims should not be construed as limiting the scope. [0157] .sup.1Peterson, A. I., E.; Schlicht, A., Capability of filling systems to dispense micro-doses of liquid pharmaceutical product. Pharmaceutical Engineering, 2007: p. 1-2 [0158] .sup.2Greb, E. (2010). “Turn Down the Fill Volume.” Pharmaceutical Technology [0159] .sup.3Cromwell, M. E. M., E. Hilario, and F. Jacobson, Protein aggregation and bioprocessing. AAPS Journal, 2006. 8(3): p. E572-E579 [0160] .sup.4Thomas, C. R. and D. Geer, Effects of shear on proteins in solution. Biotechnology Letters, 2011. 33(3): p. 443-456 [0161] .sup.5WO2016012567 [0162] .sup.6WO2014048911